Dive into a collection of past posts and rediscover timeless content.
From undervalued turnarounds and activist opportunities to fast movers and market headlines, here's what deserves your attention right now.
A diagnostics name slashed guidance, but a top asset manager kept buying as the stock fell, and a strategic review may be underway. Here’s the full breakdown.
A toy giant just put Masters of the Universe in theaters and still trades 47% below fair value at $15. Here’s why the IP story is worth a lot more than the price.
The luxury homebuilder beat Q2 on both lines, raised full-year guidance, and has a cancellation rate the rest of the industry would trade for. See if it is worth adding now.
A software compounder reports at its cheapest forward multiple in five years while the average analyst target sits 60% above the current price. Here's why it matters.
America’s largest digital auto lender swung from a net loss to $319M in profit year over year. See if the credit improvement and 11x P/E make it worth owning before Q2.
This consulting giant is trading at its cheapest forward multiple in a decade while completing a $4.18B acquisition and growing earnings steadily. Read on before the gap closes.
This industrial’s Q1 was genuinely ugly, with negative margins and near-zero earnings. See if the self-help cost story and channel destocking make it worth a small position.
This infrastructure materials name beat Q1 estimates across every segment, and the multiple has barely moved. Here’s why the gap between price and value is still wide open.